261 related articles for article (PubMed ID: 36325627)
21. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
22. Antiplatelet agents can promote two-peaked thrombin generation in platelet rich plasma: mechanism and possible applications.
Tarandovskiy ID; Artemenko EO; Panteleev MA; Sinauridze EI; Ataullakhanov FI
PLoS One; 2013; 8(2):e55688. PubMed ID: 23405196
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents.
Lin KH; Chang HC; Lu WJ; Jayakumar T; Chou HC; Fong TH; Hsiao G; Sheu JR
Platelets; 2009 Dec; 20(8):575-81. PubMed ID: 19821801
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
Goel MS; Diamond SL
J Biol Chem; 2003 Mar; 278(11):9458-63. PubMed ID: 12524437
[TBL] [Abstract][Full Text] [Related]
25. Procoagulant activity on platelets adhered to collagen or plasma clot.
Ilveskero S; Siljander P; Lassila R
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):628-35. PubMed ID: 11304482
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
27. Plasma Phospholipid Transfer Protein Promotes Platelet Aggregation.
Zhao XM; Wang Y; Yu Y; Jiang H; Babinska A; Chen XY; He KG; Min XD; Han JJ; Yang CX; Deng K; Xue J; Zhang X; Song GH; Qin SC; Jiang XC
Thromb Haemost; 2018 Dec; 118(12):2086-2097. PubMed ID: 30419596
[TBL] [Abstract][Full Text] [Related]
28. Thrombocytopathy leading to impaired in vivo haemostasis and thrombosis in platelet type von Willebrand disease.
Kaur H; Corscadden K; Ware J; Othman M
Thromb Haemost; 2017 Feb; 117(3):543-555. PubMed ID: 28004055
[TBL] [Abstract][Full Text] [Related]
29. Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen.
Pasquet JM; Dachary-Prigent J; Nurden AT
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):591-9. PubMed ID: 9677317
[TBL] [Abstract][Full Text] [Related]
30. Intracellular origin and ultrastructure of platelet-derived microparticles.
Ponomareva AA; Nevzorova TA; Mordakhanova ER; Andrianova IA; Rauova L; Litvinov RI; Weisel JW
J Thromb Haemost; 2017 Aug; 15(8):1655-1667. PubMed ID: 28561434
[TBL] [Abstract][Full Text] [Related]
31. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
[TBL] [Abstract][Full Text] [Related]
32. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH
Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766
[TBL] [Abstract][Full Text] [Related]
33. Increased blood cell phosphatidylserine exposure and circulating microparticles contribute to procoagulant activity after carotid artery stenting.
Zhao L; Wu X; Si Y; Yao Z; Dong Z; Novakovic VA; Guo L; Tong D; Chen H; Bi Y; Kou J; Shi H; Tian Y; Hu S; Zhou J; Shi J
J Neurosurg; 2017 Nov; 127(5):1041-1054. PubMed ID: 28009236
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients.
Zhao L; Bi Y; Kou J; Shi J; Piao D
J Exp Clin Cancer Res; 2016 Mar; 35():54. PubMed ID: 27015840
[TBL] [Abstract][Full Text] [Related]
35. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
[TBL] [Abstract][Full Text] [Related]
36. Insights into platelet-based control of coagulation.
de Witt SM; Verdoold R; Cosemans JM; Heemskerk JW
Thromb Res; 2014 May; 133 Suppl 2():S139-48. PubMed ID: 24862135
[TBL] [Abstract][Full Text] [Related]
37. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups.
Dachary-Prigent J; Freyssinet JM; Pasquet JM; Carron JC; Nurden AT
Blood; 1993 May; 81(10):2554-65. PubMed ID: 8490169
[TBL] [Abstract][Full Text] [Related]
38. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa.
Cox AD; Devine DV
Blood; 1994 Feb; 83(4):1006-16. PubMed ID: 7906563
[TBL] [Abstract][Full Text] [Related]
39. Platelet agonists enhance the import of phosphatidylethanolamine into human platelets.
Engelmann B; Schaipp B; Dobner P; Stoeckelhuber M; Kögl C; Siess W; Hermetter A
J Biol Chem; 1998 Oct; 273(43):27800-8. PubMed ID: 9774389
[TBL] [Abstract][Full Text] [Related]
40. The procoagulant effect of thrombin on fibrin(ogen)-bound platelets.
Sanders MW; Nieuwenhuys CM; Feijge MA; Rook M; Béguin S; Heemskerk JW
Haemostasis; 1998; 28(6):289-300. PubMed ID: 10461011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
